School of Medicine
Showing 191-200 of 578 Results
-
Cornelia L. Dekker, M.D.
Professor (Research) of Pediatrics (Infectious Diseases), Emerita
Current Research and Scholarly InterestsThe Stanford-LPCH Vaccine Program provides an infrastructure for conducting clinical studies of vaccines in children and adults. We conduct immunology studies of seasonal influenza vaccines in twins, in a longitudinal cohort of young and elderly adults and studies of various vaccine candidates for NIH and industry. Additionally, we were a CDC Clinical Immunization Safety Assessment site for 10 years working on safety issues concerning licensed vaccines.
-
Tina M. Del Cont
Product & Program Manager, Stanford Profiles, Technology & Digital Solutions
Current Role at StanfordI am the Product Manager for Stanford Profiles and Project Manager of the Stanford Profiles University-Wide Project. I work directly with the Stanford Profiles development team in Stanford Medicine | Technology & Digital Solutions Application Development. On this project, I also work with a university-wide project team, the Stanford Profiles (formerly CAP) Working Group, made up of members from many of the Stanford schools and organizations. In June of 2014, we started the CAP Drupal Module Working Group. The purpose of this group is to review and improve the integration process with CAP by expanding and enhancing the CAP Drupal Module (CAPx) with an open-source contribution approach (an initiative started and led by SWS in collaboration with the CAP Drupal Module user community).
If you are interested in becoming part of the Stanford Profiles University-Wide Project, which includes the Stanford Profiles Public and Stanford-only View web sites or would like more information on integrating your web site with Stanford Profiles, contact me at tdelcont@stanford.edu. -
Claudia Del Toro Runzer
Postdoctoral Scholar, Medical Genetics
BioClaudia Del Toro Runzer is a postdoctoral scholar at Stanford University specializing in gene therapy and regenerative medicine. Her current research focuses on developing gene editing strategies for inherited disorders, including GNE myopathy and Gaucher disease. She works on advancing precision gene engineering approaches in human hematopoietic stem and progenitor cells and other clinically relevant cell types, with the goal of enabling safe and durable therapeutic correction.
Dr. Del Toro Runzer earned her PhD in Tissue Engineering from the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University. Her doctoral research focused on chemically modified mRNA therapeutics for bone regeneration, where she investigated molecular design, intracellular trafficking, and biomaterial-assisted delivery systems to enhance protein expression and osteogenic outcomes. Her work resulted in multiple first-author publications in leading journals, including Advanced Functional Materials, Bone Research, Materials Today, and Molecular Therapy: Nucleic Acids.
Prior to her PhD, she completed an M.Sc. in Regenerative Biology and Medicine at Technische Universität Dresden and a B.Sc. in Biotechnology Engineering at Instituto Tecnológico de Monterrey. Her international training spans Germany, the Netherlands, Mexico, and the United States, with research experience in organoid systems, tissue regeneration, biomaterials engineering, and microphysiological platforms. -
Erlynn Dela Cruz
Administrative Associate, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate
